Rekord LOINC: 93308-5

Tylko wersja angielska TRIAL

Szczegóły rekordu LOINC

Informacje podstawowe

Kod LOINC:	`93308-5` FHIR
Long Common Name:	Genetic variation's effect on risk of adverse drug reaction
Short Name:	Adverse drug seq var interp Bld/T-Imp
Status:	TRIAL
Class Type:	1

Fully Specified Name (FSN)

EN Oryginalna wersja angielska

Risk of adverse drug reaction sequence variation interpretation : Imp : Pt : Bld/Tiss : Nar : -

Klasyfikacja

Class:	ENMOLPATH.PHARMG
Consumer Name:	-
Order/Observation:	Observation
Panel Type:	-

Informacje dodatkowe

Units Required:	-
Example Units:	-
UCUM Units:	-
Version Last Changed:	2.67

Definicja i opis

The predicted risk of an adverse drug reaction based on the variant(s) detected. For example, a patient who is HLA-B*57:01 positive has a significant risk of abacavir hypersensitivity reactions (HSR). For individuals taking pazopanib and found to be HLA-B*57:01 carriers, they have an increased risk of elevated alanine aminotransferase (ALT) levels when taking pazopanib.

Powiązane nazwy

Adverse drug rxn; Adverse drug seq var interp; Blood; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Narrative; Point in time; Random; React; Report; Rxn; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue